Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

93
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
93
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

73
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
73
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

95
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
95
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

305
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
305
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

91
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
91
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

2.2K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Declining age-adjusted mortality but persistent inequalities in chronic obstructive pulmonary disease in the United States, 1999-2024: a CDC WONDER analysis contextualized by GBD 2023.

Frontiers in public health·2026
Same author

Pharmacoeconomic Evaluation of Netupitant Palonosetron for Chemotherapy-Induced Nausea and Vomiting: Evidence from Economic Analyses.

Therapeutic innovation & regulatory science·2026
Same author

A waterproof and ultra-elastic thermoelectric foam for underwater human signal detection.

Nature communications·2026
Same author

Integrated Thermal-Wet Comfort Textile of Bioinspired Sweat Transportation and Triboelectric Evaporation for Personal Perspiration Management.

Nano letters·2025
Same author

Photooxidation-pyrolysis coupling for sustainable management of photocured waste: Degradation of hazardous photoinitiators and resource recovery.

Journal of hazardous materials·2025
Same author

Investigating the potential of oxidative stress-related gene as predictive markers in idiopathic pulmonary fibrosis.

Scientific reports·2025
Same journal

Validation of an updated French national tool for reporting pharmacist interventions for all healthcare products.

International journal of clinical pharmacy·2026
Same journal

Correction: Anticholinergic burden and health‑related quality of life among adult patients in a resource‑limited setting: a cross‑sectional study.

International journal of clinical pharmacy·2026
Same journal

Exploring hospital pharmacist perspectives on ethical considerations from automated patient prioritisation: a qualitative study.

International journal of clinical pharmacy·2026
Same journal

Attitudes of healthcare professionals towards the use of parenteral methotrexate in rheumatoid arthritis patients: a qualitative study.

International journal of clinical pharmacy·2026
Same journal

Patient perspectives and experiences of collaborative pharmacist prescribing in the hospital inpatient setting: a cross-sectional survey.

International journal of clinical pharmacy·2026
Same journal

Factors related to community pharmacists' intention to provide collaborative deprescribing service for fall-risk medications in older adults: a factorial and theory-based cross-sectional study.

International journal of clinical pharmacy·2026
See all related articles

Related Experiment Video

Updated: Nov 7, 2025

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
08:53

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Published on: June 6, 2025

1.0K

Pharmaceutical care program for ischemic stroke patients: a randomized controlled trial.

Jianxin Wang1, Jing Wang1, Shuocheng Qiu2

  • 1Department of Pharmacy, The First Hospital of Hebei Medical University, Shijiazhuang, 050031, Hebei, China.

International Journal of Clinical Pharmacy
|April 28, 2021
PubMed
Summary
This summary is machine-generated.

A pharmaceutical care program significantly improved medication adherence and risk factor control in ischemic stroke patients, leading to fewer hospital readmissions. This approach is key for effective secondary stroke prevention.

Keywords:
ChinaIschemic strokePharmacistsSecondary prevention

More Related Videos

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.3K
Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

22.1K

Related Experiment Videos

Last Updated: Nov 7, 2025

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
08:53

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Published on: June 6, 2025

1.0K
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.3K
Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

22.1K

Area of Science:

  • Clinical Pharmacy
  • Neurology
  • Cardiovascular Medicine

Background:

  • Effective secondary prevention strategies are crucial for reducing stroke recurrence.
  • Post-stroke care requires comprehensive management of risk factors like blood pressure, blood glucose, and lipid profiles.

Purpose of the Study:

  • To evaluate the impact of a pharmaceutical care program on risk factor control in post-stroke patients.
  • To assess the effect of pharmaceutical care on medication adherence and hospital readmissions after ischemic stroke.

Main Methods:

  • A parallel randomized-controlled study involving ischemic stroke patients.
  • Patients were assigned to either a control group (no pharmaceutical care) or an intervention group receiving monthly pharmaceutical care for 6 months.
  • Interventions included education and counseling to enhance medication adherence and risk factor management; outcomes measured included blood pressure, blood glucose, lipid profile, and medication adherence.

Main Results:

  • The intervention group showed significantly higher medication adherence rates for antihypertensive, anti-diabetic, and lipid-lowering drugs compared to the control group.
  • More patients in the intervention group achieved target levels for hemoglobin A1c and low-density lipoprotein-cholesterol.
  • Hospital readmission rates were significantly lower in the intervention group (7.14%) compared to the control group (18.3%).

Conclusions:

  • Pharmaceutical care programs are effective in improving risk factor control for secondary stroke prevention.
  • These programs enhance medication adherence and reduce hospital readmissions in patients following an ischemic stroke.